Dyne Therapeutics reports one-year DM1 trial data for z-basivarsen

September 29, 2026 4:05 PM

Dyne Therapeutics (Nasdaq: DYN) released one-year efficacy data from the multiple ascending dose portion of its Phase 1/2 ACHIEVE clinical ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found